In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.
作者信息
Belles-Isles M, Pagé M
出版信息
Br J Cancer. 1980 May;41(5):841-2. doi: 10.1038/bjc.1980.153.
Abstract
摘要
相似文献
1
In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.
Br J Cancer. 1980 May;41(5):841-2. doi: 10.1038/bjc.1980.153.
2
Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Ann N Y Acad Sci. 1983;417:262-9. doi: 10.1111/j.1749-6632.1983.tb32869.x.
3
Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.
Br J Cancer. 1985 Jul;52(1):111-6. doi: 10.1038/bjc.1985.157.
4
A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate.
J Med Chem. 1984 Dec;27(12):1602-7. doi: 10.1021/jm00378a013.
5
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Proc Natl Acad Sci U S A. 1982 Jan;79(2):621-5. doi: 10.1073/pnas.79.2.621.
6
Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7896-9. doi: 10.1073/pnas.79.24.7896.
7
Coupling daunorubicin to monoclonal antialphafoetoprotein with a new activated derivative.
Int J Immunopharmacol. 1990;12(5):503-7. doi: 10.1016/0192-0561(90)90113-2.
8
Cytotoxic effects of daunomycin-fatty acid complexes on rat hepatoma cells.
Cancer Res. 1983 Jun;43(6):2668-72.
9
[Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
Hokkaido Igaku Zasshi. 1990 May;65(3):254-65.
引用本文的文献
1
Anthracycline antibiotics in cancer therapy. Focus on drug resistance.
Drugs. 1994 Feb;47(2):223-58. doi: 10.2165/00003495-199447020-00002.
2
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Proc Natl Acad Sci U S A. 1982 Jan;79(2):621-5. doi: 10.1073/pnas.79.2.621.
3
Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.
Cancer Chemother Pharmacol. 1986;17(3):197-208. doi: 10.1007/BF00256685.
本文引用的文献
1
DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.
J Exp Med. 1965 Mar 1;121(3):439-62. doi: 10.1084/jem.121.3.439.
2
Antibodies as carriers of anticancer agents.
Lancet. 1974 Mar 23;1(7856):498-9. doi: 10.1016/s0140-6736(74)92799-8.
3
Targeting of drugs.
Nature. 1977 Feb 3;265(5593):407-11. doi: 10.1038/265407a0.
4
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
Cancer Res. 1975 May;35(5):1175-81.
Zotero 插件